Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Je Young Park"'
Autor:
Niamh Corduff, MBBS, FRACS, Je-Young Park, MD, Pacifico E. Calderon, MD, MBEth, MEd, Hosung Choi, MD, Mary Dingley, MBBS, FACCSM, FCPCA, Wilson W. S. Ho, MBChB, FRCSEd, Michael U. Martin, PhD, Lis S. Suseno, MD, Fang-Wen Tseng, MD, Vasanop Vachiramon, MD, Rungsima Wanitphakdeedecha, MD, MA, MSc, Jonathan N. T. Yu, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss 6, p e5892 (2024)
Background:. As long-term, regular aesthetic botulinum neurotoxin A (BoNT-A) use becomes more commonplace, it is vital to understand real-world risk factors and impact of BoNT-A immunoresistance. The first Aesthetic Council on Ethical Use of Neurotox
Externí odkaz:
https://doaj.org/article/be2c0341340d465c9548fd917449176c
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 5, p e5029 (2023)
Summary:. Facial skin quality profoundly influences an individual’s perceived appearance and is an important aspect of facial rejuvenation. Facial pore enlargement is one of the most common concerns among Asian individuals that adversely impacts pe
Externí odkaz:
https://doaj.org/article/25f63c1c3bd14a378f0d9944f59b400e
Autor:
Wilson W. S. Ho, MBChB, FRCSEd, Philipp Albrecht, MD, Pacifico E. Calderon, MD, MBEth, Niamh Corduff, MBBS, FRACS, David Loh, MBBS, Michael U. Martin, PhD, Je-Young Park, MD, Lis S. Suseno, MD, Fang-Wen Tseng, MD, Vasanop Vachiramon, MD, Rungsima Wanitphakdeedecha, MD, MA, MSc, Chong-Hyun Won, MD, PhD, Jonathan N. T. Yu, MD, Mary Dingley, MBBS, FACCSM, FCPCA
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 10, Iss 6, p e4407 (2022)
Background:. Botulinum neurotoxin A (BoNT-A) injection is the most widely performed aesthetic procedure and a first-line therapeutic option for various medical conditions. The potential for BoNT-A immunoresistance and secondary nonresponse related to
Externí odkaz:
https://doaj.org/article/d3d0a0c0a8e34491a526fb886264d38c
Autor:
Je-Young Park, MD, Niamh Corduff, MBBS, Jürgen Frevert, PhD, Rungsima Wanitphakdeedecha, MD, MA, MSc, Yates Y.Y. Chao, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 10, Iss 4, p e4217 (2022)
Background:. Most botulinum toxin A (BoNT/A) products contain unnecessary bacterial components that increase the risk of developing neutralizing antibodies (nAbs). Reports of secondary nonresponse and treatment failures (STF) due to nAbs have accompa
Externí odkaz:
https://doaj.org/article/6ab81a4d0cf440d89cd8f68036d36c21
Publikováno v:
Journal of Cosmetic Dermatology. 22:1805-1813
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72738ee3204dbcd6dae94cdf9a42291d
https://doi.org/10.1111/jocd.15787
https://doi.org/10.1111/jocd.15787
Autor:
JE-YOUNG PARK1, JENG-FENG CHEN2, HOSUNG CHOI3, HO, WILSON W. S.4, NI NYOMAN INDRA LESTHARI5, TENG EE LIM, JOYCE6, TING SONG LIM7, LOWE, STEPHEN8, ONG-AMORANTO, BEVERLY9, VACHIRAMON, VASANOP10, WANITPHAKDEEDECHA, RUNGSIMA11, KERSCHER, MARTINA12 martina.kerscher@uni-hamburg.de
Publikováno v:
Journal of Clinical & Aesthetic Dermatology. Jun2022, Vol. 15 Issue 6, p10-21. 12p.
Autor:
Je-Young Park, MD, Owen Sunga, MD, MSc, Rungsima Wanitphakdeedecha, MD, MA, MSc, Jürgen Frevert, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 8, Iss 1, p e2627 (2020)
Summary:. Recently launched esthetic botulinum toxin serotype A (BoNT/A) products include Nabota/Jeuveau, Meditoxin/Neuronox, and Botulax, which contain nontoxic accessory proteins and excipients. Clinical evidence supporting these formulations, incl
Externí odkaz:
https://doaj.org/article/653ce82b4da0481a9691bb6c8e55e48f
Autor:
Yan Wu, Hi‐Tae An, Nai‐Jen Hsu, David Loh, Lattaphon Malaithong, Je‐Young Park, Kyungho Park, Peter Hsien‐Li Peng, Rassapoom Sumaetheiwit, Akaluck Thammasunthorn, Almond Wibowo, Yi‐Hua Liao
Publikováno v:
Journal of Cosmetic Dermatology. 21:3779-3786
The use of hyaluronic acid (HA) fillers for medical aesthetic purposes is increasing worldwide. Nonetheless, adverse events do occur because of patient-specific issues, injection technique, or product factors. It would be mandatory to consider cultur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc3aa87cd3e5446e273a132d15dc0961
https://doi.org/10.1111/jocd.15156
https://doi.org/10.1111/jocd.15156
Publikováno v:
Aesthetic Surgery Journal.
Background In aesthetic clinical practice, botulinum toxin type A (BoNT-A) is best known for its use as a neuromodulator for the treatment of dynamic facial lines; however, when injected intradermally as microdroplets, BoNT-A can improve skin quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d4354ecbc6045e548697c2e27f1c433
https://doi.org/10.1093/asj/sjad044
https://doi.org/10.1093/asj/sjad044
Autor:
JE-YOUNG PARK1 goodmorning26@hanmail.net, LIN, FRANK1, SUWANCHINDA, ATCHIMA1, WANITPHAKDEEDECHA, RUNGSIMA1, YU, JONATHAN1, TING SONG LIM1, JENG FENG CHEN1, HO, WILSON1, LIM, JOYCE1, JUNIARTY, LANNY1, YONG SENG KEE1, SEONG JAE YOUN1, FABI, SABRINA1
Publikováno v:
Journal of Clinical & Aesthetic Dermatology. May2021, Vol. 14 Issue 5, pE70-E79. 10p.